Castle Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-19.0M | $-22.5M | $3.5M | $21.7M |
| FY2022 | $-41.7M | $-47.3M | $5.6M | $36.3M |
| FY2023 | $-5.6M | $-19.2M | $13.6M | $51.2M |
| FY2024 | $64.9M | $36.5M | $28.3M | $50.3M |
| FY2025 | $64.3M | $28.3M | $36.0M | $45.9M |